Trial Profile
Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2021
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms TARIBO
- 08 Nov 2020 Status changed from discontinued to completed.
- 12 Nov 2018 Status changed from recruiting to discontinued.
- 19 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2018.